News

Innovative Collaboration Yields Promising Brain Cancer Insights

Innovative Collaboration Yields Promising Brain Cancer Insights

Innovative Collaboration Yields Promising Brain Cancer Insights

Cordance Medical, a trailblazer in non-invasive medical technologies aimed at treating brain diseases, has joined forces with EXACT Therapeutics (Euronext Growth: EXTX) to share early data that shows remarkable potential in the treatment of brain cancer. Their groundbreaking research indicates a staggering increase of more than 127% to 145% in the uptake of a radiopharmaceutical within brain tumors in mice injected with glioblastoma cells, notorious for being one of the most aggressive and challenging brain cancers to treat.

Mechanisms Behind the Breakthrough Research

The profound results can be attributed to the innovative combination of Exact Therapeutics’ proprietary Acoustic Cluster Therapy (ACT®) and a sophisticated device engineered by Cordance Medical, which delivers ultrasound energy efficiently and non-invasively into the brain. This collaborative study was conducted at The Arctic University of Norway and University Hospital North-Norway under the expert guidance of Dr. Mathias Kranz.

Broader Applications of the Technology

This unique combination of ACT® and the advanced delivery device has extensive potential applications across various brain diseases, potentially enabling access to broader regions of the brain. By utilizing this method, therapeutic agents can be better absorbed, and the blood-brain barrier may be temporarily made more permeable in the targeted areas. Such capabilities mean that this technology could play a crucial role in both diagnostic procedures and focused therapeutic interventions for brain conditions.

Future Research and Development Plans

Currently, further investigations are underway to deepen the understanding of these initial findings. The researchers plan to compile and submit their results for publication in peer-reviewed scientific journals, contributing valuable insights to the field of oncology. The advancement of these studies is critical as it could lead to effective new treatment modalities that can significantly impact patient care.

Comments from Leadership

Dr. Bhaskar Ramamurthy, Co-founder and CEO of Cordance Medical, expressed enthusiasm over this collaborative endeavor, stating, "The combination of the Cordance technology and the ACT® microcluster technology from Exact Therapeutics provides exciting possibilities for accessing and opening larger volumes in the brain without necessarily increasing the focused ultrasound procedure time or the total amount of ultrasound energy." This statement highlights the efficiency and potential of the partnership in transforming treatment approaches.

Importance of the Ongoing Clinical Trials

Dr. Per Walday, CEO of Exact Therapeutics, emphasized the significance of these findings, noting, "These positive results in glioblastoma provide additional early evidence of the versatility of the noninvasive ACT® microcluster technology in cancer therapy. Oncology remains our primary focus, led by our ongoing Phase 2 trial in locally advanced pancreatic cancer, which received IND clearance recently." This dedication to research and development showcases their commitment to improving cancer therapeutics and patient outcomes.

About Cordance Medical

Cordance Medical is dedicated to developing innovative, non-invasive solutions tailored for treating brain diseases. Their flagship NeuroAccess™ platform is specifically designed to enable precise and targeted treatment alternatives, aiming to enhance outcomes for patients worldwide.

About EXACT Therapeutics

On the other hand, EXACT Therapeutics specializes in clinical-stage precision medicine, applying the power of ultrasound and microbubbles to offer targeted drug delivery for cancer therapies. Their Acoustic Cluster Therapy (ACT®) represents a cutting-edge methodology that can be adapted for numerous therapeutic agents, particularly within oncology and other medical areas, including brain diseases.

Frequently Asked Questions

What is the focus of the collaboration between Cordance Medical and EXACT Therapeutics?

The collaboration focuses on developing non-invasive treatments for brain cancer using innovative technologies like Acoustic Cluster Therapy and ultrasound delivery systems.

What results have been observed in the studies involving glioblastoma?

Initial results indicate a significant increase in the uptake of a radiopharmaceutical in brain tumors of glioblastoma-inoculated mice, ranging from 127% to 145%.

How does Acoustic Cluster Therapy (ACT®) work?

ACT® utilizes ultrasound and microbubbles to enhance drug delivery to targeted areas in the brain, potentially increasing efficacy and reducing side effects.

What are the future plans following these findings?

Further studies will be conducted to expand upon these findings, with results expected to be submitted for publication in scientific journals.

Why is the research on glioblastoma particularly important?

Glioblastoma is one of the most aggressive brain cancers, and developing effective treatments is crucial for improving survival rates and patient well-being.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 287

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Cambrian Turns Dairy Wastewater Into Long-Term Gas

Updated Category News Views 15

A Wisconsin dairy plant just traded lagoon duty for a 20-year service arrangement, and that is more consequential than the usual shiny renewable-gas headline. Cambrian Innovation says it has commissioned and is operating a wastewater treatment and resource recovery system that handles roughly 280,000 gallons a day. That works out to about 102 million gallons annually, a...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 71

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
LG Channels UAE Push Tests the Free Streaming Model

Updated Category News Views 102

A television's idle screen is turning into contested real estate in the UAE. LG Channels is adding programming from Rakuten TV, Stingray and Red Bull TV to its free, ad-supported service, and that matters for more than somebody hunting a movie after dinner. This is a practical push to make webOS-powered screens more useful, more frequently used and, eventually, more...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 210

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight

Updated Category News Views 56

A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 180

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Wealth Forum Puts AI and Tokenisation Before Private Wealth

Updated Category News Views 63

Private wealth is about to get squeezed from three directions at once: younger heirs, smarter machines and assets that do not fit neatly in the old family-office binder. That is the real backdrop to the Future of Wealth Forum, a new GFTN and Luxembourg House of Financial Technology partnership slated for Luxembourg City on September 27-29, 2027. It is early days,...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 164

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading

Top 5 Most Recently Viewed Articles

Embracing Harmony and Cooperation in Today's World

Updated Category News Views 99

Understanding the Essence of Hehe Culture The concept of "Hehe" in Chinese culture symbolizes harmony, peace, and cooperation, deeply embedded in the collective mindset. This philosophy, with roots extending over thousands of years, emphasizes living in balance not only with one another but also with nature and oneself. The teachings of Hehe are particularly significant...

Continue Reading
Current Trends in Mortgage Rates and Home Buying Activity

Updated Category News Views 184

The average rate for a 30-year fixed-rate mortgage dropped to 6.08% in 2024, hitting its lowest point in two years. This slight decrease from 6.09% the previous week caught the eye of potential home buyers and homeowners considering refinancing. In contrast, the average rate for a 15-year mortgage ticked up by a single basis point to reach 5.16%. These small fluctuations...

Continue Reading
Mueller Water Products Engages at 2024 Baird Industrial Conference

Updated Category News Views 195

Mueller Water Products to Engage in the Baird Industrial Conference Mueller Water Products, Inc. (NYSE: MWA), headquartered in Atlanta, is set to participate in the Baird 2024 Global Industrial Conference. This prestigious event will take place in a vibrant city known for its industrial drive and innovation. Mueller’s management team is looking forward to sharing...

Continue Reading
SANY Showcases Advanced Eco-Friendly Solutions at bauma

Updated Category News Views 389

SANY Showcases Advanced Eco-Friendly Solutions at bauma The 34th bauma, recognized as the world's leading trade fair for construction machinery, recently wrapped up in Munich. This year's theme was "The World of Efficiency, Your Partner to Create the Best", and SANY Group, in collaboration with Putzmeister, put forth an impressive display of cutting-edge technology and...

Continue Reading
Orbit International Corp Completes $1 Million Power Supply Order

Updated Category News Views 182

Orbit International Corp Secures Major Follow-On Order Orbit International Corp. (OTCID Basic Market: ORBT), a prominent player in electronic manufacturing and software solutions, has announced the receipt of a new order valued at approximately $1,000,000. This order, secured by its Orbit Power Group (OPG), pertains to a commercial power supply that is utilized in...

Continue Reading